| Name
| Country
| Market Cap (US$)
|
|---|
| Amgen, Inc. | United States | 45,914 |
| Biogen Idec Inc | United States | 18,173 |
| ImClone Systems Inc. | United States | 3,897 |
| Gen-Probe Incorporated | United States | 3,060 |
| Basilea Pharmaceutica AG | Switzerland | 1,507 |
| Hualan Biological Engineering Inc | China | 1,243 |
| ALK-Abello AS | Denmark | 1,207 |
| WuXi PharmaTech (Cayman) Inc. | China | 1,199 |
| PDL BioPharma, Inc. | United States | 1,143 |
| Shanghai Kehua Bio-Engineering Co.,Ltd | China | 1,106 |
| Beijing Tiantan Biological Products Corporation Ltd. | China | 1,096 |
| Human Genome Sciences, Inc. | United States | 773 |
| Exelixis, Inc. | United States | 725 |
| Ablynx NV | Belgium | 687 |
| AES Chemunex SA | France | 647 |
| Shin Nippon Biomedical Laboratories | Japan | 550 |
| Atrium Innovations Inc | Canada | 545 |
| Sangamo Biosciences, Inc. | United States | 542 |
| Biovitrum AB | Sweden | 525 |
| Momenta Pharmaceuticals, Inc. | United States | 514 |
|